18f-flt

Anus Neoplasms

John M. BuattiSmall moleculePhase 2Dormant

CCC

54/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 39/ 100
Competitive Position: 95/ 100

Competitive context

5 Active assets in the Anus Neoplasms cohort.

Asset / Sponsor	Phase	Rating
FLUOROURACILUM Jessa Hospital	Phase 4	BB
v503 Merck Sharp & Dohme LLC	Phase 3	BB
Capecitabine Blokhin's Russian Cancer Research Center	Phase 3	B
MITOMYCINS Blokhin's Russian Cancer Research Center	Phase 3	B
Vgx-3100 Inovio Pharmaceuticals	Phase 2	B

View all 14 →

Same molecule, other indications

18f-flt is also rated in:

acute lymphoblastic leukemiaDormant

B

Indicative ·

62 / 100

breast carcinomaDormant

B

Indicative ·

58 / 100

Stage IIB Breast CancerDormant

B

Indicative ·

58 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.